The United States is the only developed nation unable to balance cost, efficacy and social good in setting prices.
Category: Vaccines
Must-Reads Of The Week
Easy-breezy guest writer Rachel Bluth fills you in on a healthy dose of news from this past week.
KHN’s ‘What The Health?’: SCOTUS, Trump Collide Over Transgender Rights
The Trump administration rolled back protections for transgender patients just days before the Supreme Court cemented LGBTQ rights under the Civil Rights Act. So, what now? Meanwhile, coronavirus politics reaches beyond health care settings. Anna Edney of Bloomberg News, Tami Luhby of CNN and Shefali Luthra of KHN join KHN’s Julie Rovner to discuss this and more. Also, for extra credit, the panelists recommend their favorite health stories of the week they think you should read, too.
Must-Reads Of The Week
KHN executive editor Damon Darlin wades through mounds of health care policy stories — so you don’t have to.
KHN’s ‘What The Health?’: When It Comes To COVID-19, States Are On Their Own
Just about every state is lifting some coronavirus-related restrictions, but it’s unclear how things are really going, considering data on the spread of the virus lags and may not be reliable. Meanwhile, the federal government continues to throw more responsibility for dealing with the pandemic to state and local governments. Margot Sanger-Katz of The New York Times, Kimberly Leonard of Business Insider and Alice Miranda Ollstein of Politico join KHN’s Julie Rovner to discuss this and more.
Analysis: Get Ready For The Vaccine — They’re Never Simple
Trials are an immense undertaking involving tens of thousands of participants. They’re likely to start this summer — but don’t expect quick results. And what’s a successful result, anyway?
Drugmakers Tout COVID-19 Vaccines To Refurbish Their Public Image
Vaccines and antivirals have long been an afterthought but Johnson & Johnson and other firms are widely publicizing how they might stop COVID 19.
Chasing The Elusive Dream Of A COVID Cure
Thousands of researchers worldwide are looking for a treatment that will go beyond what remdesivir can do for COVID patients.
Anti-Vaccine Activists Latch Onto Coronavirus To Bolster Their Movement
Activists failed to convince state legislators that diseases like measles aren’t serious enough to require vaccination. Now they’re joining with conservatives and other anti-lockdown demonstrators who contend the coronavirus isn’t dangerous enough to justify staying home.
‘It’s Not Over Until It’s Over’: 5 Things To Know About Hitting The COVID-19 Peak
President Donald Trump says the country has seen a peak in new cases, but that doesn’t mean the end of the pandemic, experts say. Buckle in — we could be social distancing into 2022.
